Follow the people · Insider
Deborah M. Autor
Deborah M. Autor files insider transactions with the SEC as a chief policy officer of Hims & Hers Health (HIMS). We hold 2 disclosed purchases and sales filed since 28 December 2021, 1 of them in the last 90 days.
- Files forHIMS
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure20 August 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 15 November 2024 — 18 August 2026Chief Policy Officer · Hims & Hers Health (HIMS)26 Form 4 lines · source: SEC Form 4
- Filed 29 July 2022 — 11 May 2026Director · Amneal Pharmaceuticals (AMRX)18 Form 4 lines · source: SEC Form 4
- Filed 23 December 2021 — 31 August 2023Director · Pardes Biosciences (PRDS)7 Form 4 lines · source: SEC Form 4
Everything they disclosed
51 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 16,773 shares of Hims & Hers HealthSEC Form 420 August 2026Class A Common Stock · traded 18 August 2026 · filed 20 August 2026
- exercised options over 32,920 shares of Hims & Hers HealthSEC Form 418 August 2026Class A Common Stock · traded 14 August 2026 · filed 18 August 2026
- had shares withheld for tax on 16,147 shares of Hims & Hers HealthSEC Form 418 August 2026Class A Common Stock · traded 14 August 2026 · filed 18 August 2026
- exercised options over 32,920 shares of Hims & Hers Health (a derivative holding)SEC Form 418 August 2026Restricted Stock Unit · traded 14 August 2026 · filed 18 August 2026
- was granted 8,223 shares of Hims & Hers Health (a derivative holding)SEC Form 414 August 2026Restricted Stock Unit · traded 12 August 2026 · filed 14 August 2026
- exercised options over 32,919 shares of Hims & Hers HealthSEC Form 417 June 2026Class A Common Stock · traded 15 June 2026 · filed 17 June 2026
- had shares withheld for tax on 15,396 shares of Hims & Hers HealthSEC Form 417 June 2026Class A Common Stock · traded 15 June 2026 · filed 17 June 2026
- exercised options over 32,919 shares of Hims & Hers Health (a derivative holding)SEC Form 417 June 2026Restricted Stock Unit · traded 15 June 2026 · filed 17 June 2026
- exercised options over 3,656 shares of Hims & Hers HealthSEC Form 415 June 2026Class A Common Stock · traded 11 June 2026 · filed 15 June 2026
- exercised options over 3,656 shares of Hims & Hers Health (a derivative holding)SEC Form 415 June 2026Restricted Stock Unit · traded 11 June 2026 · filed 15 June 2026
- ▼ sold on the open market 34,819 shares of Amneal PharmaceuticalsSEC Form 412 May 2026Class A Common Stock · traded 11 May 2026 · filed 12 May 2026
- exercised options over 34,819 shares of Amneal PharmaceuticalsSEC Form 48 May 2026Class A Common Stock · traded 7 May 2026 · filed 8 May 2026
- exercised options over 34,819 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 48 May 2026Restricted Stock Units · traded 7 May 2026 · filed 8 May 2026
- was granted 19,824 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 48 May 2026Restricted Stock Units · traded 6 May 2026 · filed 8 May 2026
- exercised options over 32,919 shares of Hims & Hers HealthSEC Form 417 March 2026Class A Common Stock · traded 13 March 2026 · filed 17 March 2026
- had shares withheld for tax on 11,312 shares of Hims & Hers HealthSEC Form 417 March 2026Class A Common Stock · traded 13 March 2026 · filed 17 March 2026
- exercised options over 32,919 shares of Hims & Hers Health (a derivative holding)SEC Form 417 March 2026Restricted Stock Unit · traded 13 March 2026 · filed 17 March 2026
- exercised options over 32,919 shares of Hims & Hers Health (a derivative holding)SEC Form 417 March 2026Restricted Stock Unit · traded 13 March 2026 · filed 17 March 2026
- exercised options over 32,919 shares of Hims & Hers HealthSEC Form 417 March 2026Class A Common Stock · traded 13 March 2026 · filed 17 March 2026
- had shares withheld for tax on 11,312 shares of Hims & Hers HealthSEC Form 417 March 2026Class A Common Stock · traded 13 March 2026 · filed 17 March 2026
- was granted 526,711 shares of Hims & Hers Health (a derivative holding)SEC Form 413 March 2026Restricted Stock Unit · traded 11 March 2026 · filed 13 March 2026
- was granted 526,711 shares of Hims & Hers Health (a derivative holding)SEC Form 413 March 2026Restricted Stock Unit · traded 11 March 2026 · filed 13 March 2026
- ▼ sold on the open market 7,054 shares of Hims & Hers HealthSEC Form 418 December 2025Class A Common Stock · traded 17 December 2025 · filed 18 December 2025
- exercised options over 7,054 shares of Hims & Hers Health (a derivative holding)SEC Form 416 December 2025Restricted Stock Unit · traded 15 December 2025 · filed 16 December 2025
- exercised options over 7,054 shares of Hims & Hers HealthSEC Form 416 December 2025Class A Common Stock · traded 15 December 2025 · filed 16 December 2025
- was granted 3,656 shares of Hims & Hers Health (a derivative holding)SEC Form 48 August 2025Restricted Stock Unit · traded 6 August 2025 · filed 8 August 2025
- exercised options over 6,175 shares of Hims & Hers Health (a derivative holding)SEC Form 416 June 2025Restricted Stock Unit · traded 12 June 2025 · filed 16 June 2025
- exercised options over 6,175 shares of Hims & Hers HealthSEC Form 416 June 2025Class A Common Stock · traded 12 June 2025 · filed 16 June 2025
- exercised options over 40,258 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 48 May 2025Restricted Stock Units · traded 5 May 2025 · filed 8 May 2025
- was granted 34,819 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 48 May 2025Restricted Stock Units · traded 6 May 2025 · filed 8 May 2025
- exercised options over 40,258 shares of Amneal PharmaceuticalsSEC Form 48 May 2025Class A Common Stock · traded 5 May 2025 · filed 8 May 2025
- ▼ sold on the open market 6,771 shares of Amneal PharmaceuticalsSEC Form 425 November 2024Class A Common Stock · traded 21 November 2024 · filed 25 November 2024
- ▼ sold on the open market 33,229 shares of Amneal PharmaceuticalsSEC Form 425 November 2024Class A Common Stock · traded 22 November 2024 · filed 25 November 2024
- was granted 21,164 shares of Hims & Hers Health (a derivative holding)SEC Form 419 November 2024Restricted Stock Unit · traded 15 November 2024 · filed 19 November 2024
- was granted 6,175 shares of Hims & Hers Health (a derivative holding)SEC Form 419 November 2024Restricted Stock Unit · traded 15 November 2024 · filed 19 November 2024
- ▼ sold on the open market 14,553 shares of Amneal PharmaceuticalsSEC Form 420 May 2024Class A Common Stock · traded 16 May 2024 · filed 20 May 2024
- ▼ sold on the open market 23,447 shares of Amneal PharmaceuticalsSEC Form 420 May 2024Class A Common Stock · traded 17 May 2024 · filed 20 May 2024
- exercised options over 76,453 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 414 May 2024Restricted Stock Units · traded 10 May 2024 · filed 14 May 2024
- exercised options over 76,453 shares of Amneal PharmaceuticalsSEC Form 414 May 2024Class A Common Stock · traded 10 May 2024 · filed 14 May 2024
- was granted 40,258 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 46 May 2024Restricted Stock Units · traded 2 May 2024 · filed 6 May 2024
- returned to the issuer 37,500 shares of Pardes Biosciences (a derivative holding)SEC Form 431 August 2023Stock Option (Right to Buy) · traded 31 August 2023 · filed 31 August 2023
- returned to the issuer 70,390 shares of Pardes Biosciences (a derivative holding)SEC Form 431 August 2023Stock Option (Right to Buy) · traded 31 August 2023 · filed 31 August 2023
- returned to the issuer 75,000 shares of Pardes Biosciences (a derivative holding)SEC Form 431 August 2023Stock Option (Right to Buy) · traded 31 August 2023 · filed 31 August 2023
- returned to the issuer 37,500 shares of Pardes Biosciences (a derivative holding)SEC Form 431 August 2023Stock Option (Right to Buy) · traded 31 August 2023 · filed 31 August 2023
- exercised options over 54,949 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 41 August 2023Restricted Stock Units · traded 30 July 2023 · filed 1 August 2023
- exercised options over 54,949 shares of Amneal PharmaceuticalsSEC Form 41 August 2023Class A Common Stock · traded 30 July 2023 · filed 1 August 2023
- was granted 37,500 shares of Pardes Biosciences (a derivative holding)SEC Form 42 June 2023Stock Option (Right to Buy) · traded 1 June 2023 · filed 2 June 2023
- was granted 76,453 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 411 May 2023Restricted Stock Units · traded 9 May 2023 · filed 11 May 2023
- was granted 54,949 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 42 August 2022Restricted Stock Units · traded 29 July 2022 · filed 2 August 2022
- was granted 37,500 shares of Pardes Biosciences (a derivative holding)SEC Form 410 June 2022Stock Option (Right to Buy) · traded 8 June 2022 · filed 10 June 2022
- was granted 75,000 shares of Pardes Biosciences (a derivative holding)SEC Form 428 December 2021Stock Option (Right to Buy) · traded 23 December 2021 · filed 28 December 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.